• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Molecular pathobiological studies on the multi-functional SERPIN, protein C inhibitor-dependent diseases

Research Project

Project/Area Number 14370055
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionMie University

Principal Investigator

SUZUKI Koji  Mie University, Faculty of Medicine, Professor, 医学部, 教授 (70077808)

Co-Investigator(Kenkyū-buntansha) ESTEBAN Gabazza  Mie University, Faculty of Medicine, Assistant Professor, 医学部, 助手 (00293770)
KAMADA Haruhiko  Mie University, Faculty of Medicine, Assistant Professor, 医学部, 助手 (00324509)
HAYASHI Tatsuya  Mie University, Faculty of Medicine, Lecturer, 医学部, 講師 (00242959)
WADA Hideo  Mie University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (40158704)
Project Period (FY) 2002 – 2003
Keywordsprotein C inhibitor / serpin / uPA / activated protein C / renal cell carcinoma / CpG methylation / transgenic mice / pro-inflammatory factor
Research Abstract

Protein C inhibitor (PCI), a member of the SERPIN family, is produced in various human tissues, including the liver, kidney, and testis. In addition to inhibit the anticoagulant protein C pathway, PCI also inhibits urinary uPA, which is a well-known mediator of tumor cell invasion. (1) To clarify the biological significance of PCI in the kidney, we compared the expression of PCI between human renal cell carcinoma (RCC) tissue and non-tumor kidney tissue. The PCI level in RCC tissue was found to be significantly lower than in non-tumor kidney tissue, and expression of PCI mRNA was detected in normal renal proximal tubular epithelial cells, but not in RCC nor in an RCC cell line (Caki-1cells). Methylation of some CpG islands in the promoter region of PCI gene was detected from RCC cell lines, but not from non-tumor kidney cells. The in vitro invasiveness of Caki-1 cells transfected with a PCI expression vector was significantly decreased compared to mock-transfected Caki-1 cells. These f … More indings suggest that PCI regulates the invasive potential of RCC cells by inhibiting uPA secreted by these cells. (2) Moreover, we produced human PCI gene-transgenic (TG) mice and characterized the tissue distribution and biological functions of PCI expressed in the TG mice. Northern blot and immunohistochemical analyses showed that in the TG mice the human PCI is expressed not only in the reproductive organs such as testis, ovary and uterus, but also in the liver hepatocytes, renal epithelial cells, heart and brain; these tissue distribution of the PCI being similar to that in humans. The PCI expressed in the TG mice efficiently inhibited the anticoagulant and anti-inflammatory activities of the extraneously injected human activated protein C (APC) in the TG mice by forming a complex with APC. These findings demonstrate that human PCI gene TG mice are useful as experimental animal models to evaluate pathological significance of human PCI and also therapeutic effects of human APC in vivo. Less

  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Suzuki, K., Gabazza, E.C., et al.: "Protective role of activated protein C in lung and airway remodeling."Crit.Care Med.. 32. 262-265 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hayashi, T., Suzuki, K., et al.: "Characterization of mice transgenic for a human protein C inhibitor gene, useful as in vivo models for the evaluation of the therapeutic effects of humanactivated protein C."J.Thromb. Haemost.. 2. 949-961 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wakita, T., Suzuki, K., et al.: "Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma."Int.J.Cancer. 108. 516-523 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yuda, H., Suzuki, K., et al.: "Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in the mouse."Blood. 103. 2196-2204 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takeya, H., Suzuki.K., et al.: "Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells."Blood. 102. 1696-1700 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fujimoto, H., Suzuki, K., et al.: "Thrombin-activateble fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease."Am.J.Respir.Crit.Care Med.. 167. 1687-1694 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu, S., Suzuki, K., et al.: "Activated protein C inhibits the expression of platelet-derived growth factor in the lung."Am.J.Respir.Crit.Care Med.. 167. 1416-1426 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Gabazza, E.C., Suzuki, K., et al.: "Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism."Clin.Science. 102. 167-175 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 鈴木 宏治 (鈴木宏治, 一瀬白帝 編): "図説 分子病態学 3版"中外医学社 東京. 501 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki, K., et al.: "Protective role of activated protein C in lung and airway remodeling."Clit. Care Med.. 32. 262-265 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hayashi, T., et al.: "Characterization of a novel human protein C inhibitor gene transgenic mouse useful for studying the role of PCI in physiological and pathological condition."J. Thromb. Haemost.. 2. 949-961 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wakita, T., et al.: "Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma."Int. J. Cancer. 108. 516-523 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yuda, H., et al.: "Activated protein C inhibits bronchial hyper-responsiveness and The cytokine expression in the mouse."Blood. 103. 2196-2204 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takeya, H., et al.: "Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissuefactor expression in endothelial cells."Blood. 102. 1693-1700 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fujimoto, H., et al.: "Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease."Am. J. Respir. Crit. Care Med.. 167. 1687-1694 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu, S., et al.: "Activated protein C inhibits the expression of platelet-derived growth factor in the lung."Am. J. Respir. Crit. Care Med.. 167. 1416-1426 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Gabazza, E.C., et al.: "Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism."Clin. Science. 102. 167-175 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi